PSNL Personalis, Inc.
P/E
--
Forward P/E
--
Price/Sales
24.3
Beta
2.322
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Personalis total revenue grew 76% in third quarter 2026 amid clinical volume surge
Personalis reported a significant 76% year-over-year revenue increase to $25.6 million, driven by a pivot toward clinical diagnostics and population...
Personalis Inc Q3 2026 Earnings Preview: What Analysts Expect on November 03, 2026
For Q3 2026, analysts expect Personalis to report revenue of $21.54 million and an EPS loss of $0.26, with the stock currently trading at $16.00, slightly...
Casdin Capital boosts Personalis stake by 59% ahead of acquisition news
Casdin Capital significantly increased its holding in Personalis (PSNL), a cancer genomics company, during the second quarter of 2026. According to a recent...